{"id":"https://genegraph.clinicalgenome.org/r/1007f0db-d0fc-4ed6-85a8-db5240b10676v1.0","type":"EvidenceStrengthAssertion","dc:description":"*HBA1* was first reported in relation to autosomal dominant erythrocytosis 7 in 1966 (Clarache et al. 1966; PMID: 5913291). Erythrocytosis 7 is a disorder of the blood characterized by a high concentration of erythrocytes in the blood and an increased oxygen affinity of hemoglobin. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, we found differences in molecular mechanisms, inheritance pattern, and phenotypic variability in erythrocytosis 7 relative to other disease entities associated with *HBA1*. Therefore, the following disease entities have been split into curations; AD erythrocytosis, AD and AR alpha-thalassemia, unstable hemoglobin disease, and methemoglobinemia. This curation addresses only AD erythrocytosis. This curation includes at least 8 missense and 1 indel variants reported in 9 probands with AD erythrocytosis in 9 publications (PMIDs: 5913291, 11123, 701083, 3973024, 3667323, 3142772, 14649314, 24200101, 28532286). Variants in this gene segregated with disease in 15 additional family members (PMID: 5913291). This gene disease association is also supported by experimental evidence including expression, biochemical function, and protein-protein interactions (PMIDs: 11747442, 6644819).  In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen General Gene Curation Expert Panel on 10/25/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1007f0db-d0fc-4ed6-85a8-db5240b10676","GCISnapshot":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2023-10-25T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2024-06-28T18:47:22.340Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a53a3211-6c9b-4ba1-95ca-5595decbc29d","type":"EvidenceLine","dc:description":"The GCEP decided to upgrade this evidence in previous curations on the globin genes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dc3e621-6ccb-40d6-bf64-6c303717fbd5","type":"Finding","dc:description":"The ability to bind and release oxygen is relevant to erythrocytosis, a disease characterized by an increased oxygen affinity of hemoglobin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11747442","rdfs:label":"Kidd Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1259764f-1832-4f8e-bc04-54f233c833a8","type":"EvidenceLine","dc:description":"The GCEP decided to upgrade this evidence in previous curations on the globin genes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dc6f6e0-2170-4f77-80ba-f43c7ec092ae","type":"Finding","dc:description":"HBA1 protein physically interacts with the HBB gene product. This has been well-documented in the literature, and is shown here in a representative piece of evidence from an X-ray crystal structure of the hemoglobin complex in the oxygen-bound state. HBB encodes the beta-chain of hemoglobin and harbors missense variants associated with erythrocytosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6644819","rdfs:label":"Shaanan Protein-Protein","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7f0ed0fe-c008-470b-ac06-6378058ae7bc","type":"EvidenceLine","dc:description":"The GCEP upgraded this evidence in previous curations on the globin genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bdaa7f1-a411-445b-b8b4-996d70809b97","type":"Finding","dc:description":"Genotype-Tissue Expression (GTEx) shows that HBB is primarily expressed in whole blood, which is the tissue of interest for erythrocytosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32913098","rdfs:label":"GTEx Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df23db1a-3b2f-497f-87c4-556c51e7bdd6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b87289c-c21d-4e6b-ae58-cf2c2ea02610_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/5913291","rdfs:label":"Clarache_Family","estimatedLodScore":4.82,"family":{"id":"https://genegraph.clinicalgenome.org/r/2b87289c-c21d-4e6b-ae58-cf2c2ea02610","type":"Family","rdfs:label":"Clarache_Family","member":{"id":"https://genegraph.clinicalgenome.org/r/35e21b74-0f66-4b26-bd17-3c291ca27c2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/5913291","rdfs:label":"Clarache_1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":81,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8b0c4d0f-2ae0-4ea0-92f5-a72bb2ffd702","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.278G>T (p.Arg93Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125697"}},"detectionMethod":"Peptide mapping and amino acid analysis was performed","firstTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c85dfa5-ade1-4e21-9b27-4b3591d36dc9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/5913291","allele":{"id":"https://genegraph.clinicalgenome.org/r/8b0c4d0f-2ae0-4ea0-92f5-a72bb2ffd702"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":16,"phenotypes":["obo:HP_0000006","obo:HP_0001900","obo:HP_0001901","obo:HP_0001899"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/35e21b74-0f66-4b26-bd17-3c291ca27c2f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e5c8ccfe-1d04-40df-9645-83d8a2f87b6b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5c8ccfe-1d04-40df-9645-83d8a2f87b6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant exhibits a 6-7-fold  increase in O2 affinity compared to HbA","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e5c8ccfe-1d04-40df-9645-83d8a2f87b6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3142772","allele":{"id":"https://genegraph.clinicalgenome.org/r/60f31a48-357c-43e3-8188-a4b7234ef8c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.265G>T (p.Ala89Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6493e27e-cb22-4698-92cc-be0adb2f72ae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6493e27e-cb22-4698-92cc-be0adb2f72ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a 6-fold increase in O2 affinity, a  reduced Bohr effect, and low cooperativity compared to WT","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6493e27e-cb22-4698-92cc-be0adb2f72ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11123","allele":{"id":"https://genegraph.clinicalgenome.org/r/ebeec05e-f6cd-4348-ba6c-8d0a07bd43ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.425G>A (p.Arg142His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125901"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bfe647b5-8fde-42ad-b286-9cb08bcf84d7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfe647b5-8fde-42ad-b286-9cb08bcf84d7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bfe647b5-8fde-42ad-b286-9cb08bcf84d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28532286","allele":{"id":"https://genegraph.clinicalgenome.org/r/ff278257-e5c4-4502-bc00-a3338fa6df81","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.151_152insGGAGCC (p.Ser50_His51insArgSer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580650490"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7fe0409f-b1c7-492b-bbef-c34a608fbd4c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fe0409f-b1c7-492b-bbef-c34a608fbd4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Sanna et. al 1994, PMID: 7518430 showed that the variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7fe0409f-b1c7-492b-bbef-c34a608fbd4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3667323","allele":{"id":"https://genegraph.clinicalgenome.org/r/acb88d0c-5c6d-46db-bf78-31e721fd34de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.379G>C (p.Asp127His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125875"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a4fe8758-b837-4064-b2a4-a50ce69ba6db","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4fe8758-b837-4064-b2a4-a50ce69ba6db_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a4fe8758-b837-4064-b2a4-a50ce69ba6db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/701083","allele":{"id":"https://genegraph.clinicalgenome.org/r/46fc21d4-740c-42dc-b1f6-bdd7f743d8e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.425G>T (p.Arg142Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125809"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8ad66c1b-5e50-43a7-b2da-e84cad47899c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ad66c1b-5e50-43a7-b2da-e84cad47899c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a hyperbolic Hb-oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8ad66c1b-5e50-43a7-b2da-e84cad47899c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14649314","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d1402ee-3157-45ae-b9b1-2b319f456d20","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.123G>C (p.Lys41Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126007"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3c85dfa5-ade1-4e21-9b27-4b3591d36dc9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c85dfa5-ade1-4e21-9b27-4b3591d36dc9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3c85dfa5-ade1-4e21-9b27-4b3591d36dc9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c93084bd-0d4e-407e-9b35-be3de575a6d5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c93084bd-0d4e-407e-9b35-be3de575a6d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24200101","allele":{"id":"https://genegraph.clinicalgenome.org/r/b8b53c54-2063-4841-ba31-c1ac211078ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.287C>G (p.Pro96Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125893"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/57a9df98-903b-469a-8711-3045d35448da","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57a9df98-903b-469a-8711-3045d35448da_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/57a9df98-903b-469a-8711-3045d35448da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3973024","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd0690a1-a837-46d8-a35f-a710ba19f9e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.424C>T (p.Arg142Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125845"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.1}],"evidenceStrength":"Moderate","sequence":8549,"specifiedBy":"GeneValidityCriteria10","strengthScore":7.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/faxNYOLN5bY","type":"GeneValidityProposition","disease":"obo:MONDO_0054802","gene":"hgnc:4823","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_df23db1a-3b2f-497f-87c4-556c51e7bdd6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}